Pfizer's net profit under GAAP for 6 months of 2020 was $6.845 billion, down 23.5% from $8.945 billion the previous year. Revenues decreased by 9.7% to $23,829bn from $26,382bn a year earlier.
Pfizer's net profit under GAAP for 6 months of 2020 was $6.845 billion, down 23.5% from $8.945 billion the previous year. Revenues decreased by 9.7% to $23,829bn from $26,382bn a year earlier. 
investors.pfizer.com
English (US) 